Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.4 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.4 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.4 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |